Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Casgevy (exa-cel)
Pharma
As Vertex's pain launch gains more use, sales just missed in Q3
Sales for three key launch products for Vertex came up short of expectations in the third quarter, including for non-opioid pain reliever Journavx.
Kevin Dunleavy
Nov 4, 2025 8:40am
UPDATED: Most expensive drugs in the US in 2025
Aug 11, 2025 3:00am
Vertex's proposed fertility support program shot down in court
Apr 1, 2025 11:48am
Vertex's Casgevy breaks ground with 1st commercial infusions
Nov 5, 2024 12:19pm
Vertex adds CDMO Lonza to Casgevy production network
Sep 24, 2024 9:41am
Bluebird down 18% with slow uptake of SCD gene therapy Lyfgenia
Aug 14, 2024 12:07pm
